At the time we first started pursuing this litigation, Mounjaro was probably the only label that listed something related to gastroparesis, but it is in no way adequate
[2] Wegovy works partly by slowing gastric emptying, which can lead to nausea, vomiting, diarrhoea, and abdominal discomfort, particularly during dose escalation
DIE FONDS FR IHR PORTFOLIO Willkommen Schn, dass Sie uns besuchen
Long-Term Use Significant skin brightening, anti-aging benefits, and enhanced overall wellness
We think this means that GLP-1 receptor agonist drug use could continue to grow in the next 5 years, to a point where we could see at least 5% of the population of most advanced and upper-middle income countries using them routinely